Displaying drugs 14126 - 14150 of 14715 in total
4-Fluorobenzylamine
Experimental
2,6-Difluorobenzenesulfonamide
Experimental
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea
Experimental
3-Iodo-Benzyl Alcohol
Experimental
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol
Experimental
4-(trifluoromethyl)phenol
Experimental
2-Iodobenzylthio Group
Experimental
N-phenylthiourea
Experimental
Coelenteramide
Experimental
Balanol
Experimental
AL6528
Experimental
Asimadoline
Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of...
Investigational
Matched Description: … has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and …
Refametinib
Investigational
Displaying drugs 14126 - 14150 of 14715 in total